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We use data from a randomized controlled trial on preventive home visits (PHVs) exploring 
effectiveness on health-related quality of life (HRQoL). In this article we examine the intervention’s 
cost effectiveness and effects on quality-adjusted life years (QALYs) in older home-dwelling adults. 
Methods 
There were 422 independently home-dwelling participants in the randomized, controlled trial, all aged 
over 75 years, with equal numbers in the control and intervention groups. The intervention took place 
in a municipality in Finland and consisted of multiprofessional PHVs. We gathered the data on health-
care and social services use from central registers and medical records during one year before the 
intervention and two years after the intervention. We analyzed the total health-care and social services 
use and costs per person years and the difference in change in HRQoL as measured using the 15D 
measure. We calculated QALYs and incremental cost-effectiveness ratios (ICERs). 
Results 
There was no significant difference in baseline use of services or in the total use and costs of health-
care and social services during the two-year follow-up between the two groups. In the intervention 
group HRQoL declined significantly more slowly compared to the control group (-0.015), but there 
was no significant difference in QALYs gained between the groups. The cost-effectiveness plane 
showed 60% of ICERs lying in the dominant quadrant, representing additional effects with lower 
costs.  
Conclusions 
This multiprofessional PHV intervention appears to have positive effects on HRQoL without accruing 
additional costs. 
Keywords : Preventative Health Care; Health Services; Geriatric Assessment; Primary Care; Cost 
Effectiveness  






















Aging populations are a modern demographic trend in many societies.  This phenomenon has wide-
ranging implications for a society and its citizens, including implications for expenditures on health 
care and social services. (1). The use of preventive home visits (PHVs) has been studied as a means to 
support the well-being of older adults and to postpone the onset of disabilities (2-4). Interventions 
designed to reduce disability might result in lower costs for health care and social services if they have 
the potential to reduce hospitalizations and institutionalizations (2,5). This reasoning has led to 
preventive measures, including PHVs, to be included as part of national health care policy in some 
countries, such as Denmark, the U.K., and Australia (5). 
Although PHVs have been studied for decades, there is little evidence regarding their cost 
effectiveness (3,5). Some studies have suggested that PHV interventions decrease hospitalizations and 
nursing home admissions, and that they shorten hospital stays; thus, they may have positive effects on 
health care costs (6-9). However, the evidence has been contradictory in other studies (3,10). Our 
earlier review suggested that some PHV programs might yield favorable results in well-being, 
functioning, and mortality, and that they are cost neutral (3).  
Older people reported social aspects and well-being important when considering PHV intervention 
contents and outcomes (11).  However, research on well-being and health-related quality of life 
(HRQoL) and cost effectiveness related to it has lagged behind (12). The few existing studies have 
yielded varying results concerning both HRQoL and costs (2,5,12). A recent meta-analysis found the 
proactive care interventions targeted to older people are unlikely to be cost-effective after one year, 
but the heterogeneity of the interventions and evaluation of the effects on the group level might have 
diluted the results (13). However, both older people and professionals have evaluated proactive 
multidisciplinary care positively, and it warrants for further research (11,13). 
We have previously reported on a randomized, controlled trial (RCT) on the effectiveness of 
multiprofessional PHVs on HRQoL of older home-dwelling individuals (age 75+). The participants 
received no regular home help or care and the trial was conducted in Finland (14). Our study indicated 
the intervention might slow down the decline in the HRQoL of older adults. We report here on an 
analysis of the effects of the intervention on the participants’ use of health-care and social services and 
related costs, as well as an analysis of the cost effectiveness of the intervention. 
2 Methods 
2.1 Design 
We performed a randomized, controlled, single-center trial in Finland, including a two-year follow-up, 
focusing on the effects of PHVs on HRQoL and on the use of and costs related to the use of health 
care and social services. We have described the methods used, the baseline findings, the feasibility of 
the intervention, and the primary clinical outcomes in detail in earlier papers (14-15). We provided 
oral and written information to all participants and participants provided their written informed 
consent. The Ethics Committee of the Helsinki University Central Hospital provided ethics approval 





















2.2 Participants and setting 
We recruited 422 participants to take part the study in 2013. A letter about the study was sent to all 
2,692 residents aged 75 years or older in Hyvinkää, which is a mid-size Finnish town with 46,600 
inhabitants. We included in the pool of potential participants all those who were 75 years old or older, 
home dwelling, not receiving home help or nursing services, living permanently in the Hyvinkää area, 
and Finnish speaking. We recruited from those who returned a letter showing an interest in 
participating in the study (n = 968) the first consecutive 422 individuals who met the inclusion criteria 
and who provided their informed consent (Figure 1). We used computer-generated random numbers 
from Research Randomizer (16), seeded by the computer's clock, after the baseline assessment to 
randomize participants into the intervention (n = 211) and control (n = 211) groups. Two 
randomizations were performed as 62 spouses were randomized together to avoid dilution of the 
intervention effect.  
2.3 Measures and study procedures 
Data were collected using the same postal survey at baseline and at one- and two-year follow-up time 
points. Baseline items included social demographics (gender, age, marital status, and education), 
current weight and height, current medications, use of assistive devices, diagnoses, health habits, and 
risk factors (smoking, use of alcohol, exercise habits, and falls during the past six months). Data on the 
use and costs of health-care and social services for one year before the intervention (baseline) and at 
the two-year follow-up were collected from health-care information systems and databases. We 
performed the assessments and interventions in 2013 and 2014. To explore the cost effectiveness of 
the intervention we compared the groups in respect to their health-care and social services use and the 
related costs during the two-year follow-up after the intervention. 
We measured the utilization and costs of health-care and social services in detail from central registers 
and medical records for one year before the intervention and for two years after the initial home visit 
or until the participant’s death. The use of hospital services and community care services in Finland is 
reliably recorded in medical records and central registers. All visits to primary care physicians and 
nurses, visits with other healthcare specialists (like physiotherapists, occupational therapists, 
nutritionists), home-care visits, time spent at day centers, days spent in institutions (various hospitals, 
nursing homes, or long-term care hospitals), and visits to specialist doctors during the two-year 
follow-up were retriev d from central registers, from patient medical records in their primary care and 
area hospitals, and from social care registers. These data were collected from Population Register 
Centre, Kanta Patient Data Repository, Pegasos patient information system for medical and social 
services records of the municipality and Navitas reference database for community care services 
received outside Hyvinkää municipality and hospital services. Health-care and social service costs 
were determined using mean unit costs for Finland for year 2011 reported by the Finnish National 
Institute for Health and Welfare (17), with an appropriate correction added for the inflation rate based 
on the official cost-of-living index. Total costs were calculated by multiplying the number of health 
and social care services utilization units with cost prices of each unit. Costs are presented in Euros (€). 
Intervention costs were calculated according to the unit costs for each of the three home visits.  
The primary outcome measure, as reported in our earlier papers, was HRQoL as assessed using the 
measurement tool referred to as the 15D. As a generic assessment measurement, this 15-item 
questionnaire can be used as a profile measurement or as a single index. The domains of assessment of 




















activities, mental function, discomfort and symptoms, depression, distress, vitality, and sexual activity. 
In the trial we used the 15D data as an index score which varied between 0 (poorest HRQoL) and 1 
(excellent HRQoL). We sent the 15D as a postal questionnaire since the 15D can be independently 
filled out. The questionnaire was sent at baseline and at one- and two-year follow-up time points, and 
the participants were asked to answer according to their current health status. 
Mortality data were retrieved from central registers. The Finnish register system’s follow-up on 
mortality is 100% complete. 
2.4 Intervention 
Briefly, participants in the intervention group received three PHVs in which a thorough 
comprehensive geriatric assessment (18-19) was conducted using validated measurement tools.  
Recommendations and actions were taken based on the assessment results. The home visits were 
performed by specially trained nurses, by a physiotherapist, and by a social worker, in this order, 
during a six- to nine-month period. The professionals performing the home visits were thoroughly 
trained. The control group received standard care, and, thus, all health and social care services offered 
by the municipality were available to them when needed. In addition, they received and answered the 
same postal questionnaires as the intervention group. We have described the intervention in more 
detail earlier (14-15). 
The first part of the assessment was performed by the nurse, who measured the participants’ blood 
pressure and blood glucose levels and conducted a thorough assessment of their health and functioning 
using a battery of validated measures (interRAI Home Care Assessment System [20], Mini-Mental 
State Examination [21], Mini Nutritional Assessment [22], Barthel scale [23], The 15-item Geriatric 
Depression Scale [24], and Instrumental Activities of Daily Living [IADL] [25]).  
The physiotherapist assessed home safety and barriers to mobility using validated tests (Falls Risk for 
Older People – Community setting screen [26]), assessed the need for aids, measured hand grip 
strength (Jamar [27]) and performed a chair-stand test (CS-5 [28]).  
The social worker assessed social functioning, activities of daily living (ADL, IADL [20,25]), and 
service needs.  
In addition to administ ring the assessment tools, the nurse formulated individualized plans with the 
participants for further actions and made a referral to a GP if necessary. The physiotherapist compiled 
individualized exercise plans, gave information on exercise groups available, and made a referral for 
physiotherapy sessions if necessary, and the social worker provided information on benefits available 
to the participants and provided contact information for a service provider. The physiotherapist and 
social worker filled in instructions on the information card when needed. 
2.5 Statistical analyses 
Sample size was estimated based on the 15D, our primary outcome measure. The calculation was 
based on a change of 0.03 points in the 15D index score (17). In prior studies the standard deviation in 
the 15D score was 0.15 (29). Based on the calculation, we would need a minimum sample size of 196 
study participants per study arm for a Type 1 Error of 5% and a power of 80%. All randomized 
participants were included in the analysis of use and costs of health care and social services (intention 




















Statistical comparisons between the groups were made using the t-test, the bootstrap type t-test, or the 
chi-square test when appropriate. Mean changes in the 15D score were assessed using the mixed-
model repeated measure methods with treatment, visit, and treatment–visit interaction as fixed effects; 
the model included the baseline score as a covariate. Comparisons between the groups for costs were 
made using the bootstrap type t-test and generalized Hodges-Lehmann median differences. 
Means ratio with a 95 % confidence interval (CI) for cost was modeled using generalized linear 
models with a log link function and a gaussian distribution.  Bias-corrected bootstrapping (10,000 
replications) was used to obtain the CIs for the means because of the skewed distribution of the use 
and costs of health-care and social services. Outcomes for the cost-utility analysis are expressed in 
terms of generic quality-adjusted life years (QALYs), measured using the 15D. All participants who 
completed the baseline and at least one follow-up assessment were included for the 15D and QALY 
analysis. For a health economic evaluation, we performed a cost-utility analysis in relation to QALY 
derived from the area under the curve calculation for the 15D score from baseline to last follow up. 
Data for the cost-utility analysis were collected at the baseline, at 12 months, and at 24 months. We 
evaluated the incremental cost-effectiveness ratio (ICER) as being the ratio of the mean difference in 
cost to the mean difference in effect. Missing values for follow-up observations of 15D (intervention n 
= 22  and control n = 26) were imputed using multiple imputation by chained equations (30). The 
imputation model included all analysis variables (Table 1). Multiple data sets (N=10) were generated 
to account for the uncertainty in imputed data. All statistical analyses were performed using Stata 
statistical software version 15.1 (StataCorp, College Station, Texas, USA). 
 
3 Results 
We included 422 participants in the study, randomized equally into the intervention group or the 
control group. The baseline characteristics were well balanced between the randomized groups. The 
mean age of the participants was 81 years and 65% were females. The groups were similar with 
respect to years of education and comorbidities, and there was no significant difference in HRQoL 
according to 15D scores at baseline. There were no differences between the intervention and control 
group in terms of health- and social-care use during the year previous to the intervention (Table 1).  
3.1 Use and Costs of Health and Social Services 
Table 2 shows the mean use and costs of health care and social services per person years for the 
intervention and control groups during the 24-month follow-up. Mean and median total cost per 
person year for the 24-month follow-up was mean 6929€ (SE 846) and median 1848€ (IQR: 837 , 
7341) in the intervention group and mean 8277€ (SE 1089) and median 2485€ (IQR: 1049 , 7231) in 
the control group. The difference between the intervention and control groups was not significant 
(mean difference -1349€ [-4119€ to 1172€] and median difference -258€ [-711€ to 157€]). The 
intervention costs were 382€ per participant. Including the intervention costs in the total costs for the 
intervention group did not change the findings, with the mean total costs per person at 24-month 
follow-up being 7310€ (SE 849) for the intervention group. The mean difference between groups 
when including intervention costs was -967€ (-3766 to 1633) (mean ratio 0.84 [0.55 to 1.13]). 
In the intervention group HRQoL declined significantly more slowly compared to in the control group 




















0.819 (SD 0.112) in the intervention group whereas the respective figure in the control group was 
0.812 (SD 0.114). The difference in QALYs was -0.007 (95% CI -0.029 to 0.015; p=0.52) and after 
performing an imputation -0.005 (95% CI -0.035 to 0.022; p=0.48). 
The cost-effectiveness plane for the cost-utility analysis bootstrap analysis for QALYs (Figure 2) 
shows that 60% of the ICERs lie in the dominant (“south east”) quadrant that represents the 
probability of the intervention having more effect and lower costs compared with usual care. Thus, we 
can conclude that the intervention retained HRQoL cost-neutrally. 
4 Discussion 
In this analysis, based on data from an RCT, we explored the cost effectiveness of multiprofessional 
PHVs that included a comprehensive geriatric assessment for older adults. We found no significant 
difference between the intervention group and the control group in terms of use and costs of health and 
social services or in the QALYs gained. Yet, HRQoL declined significantly more slowly for the 
intervention group during the first year of follow up and 60% of ICERs lay in the dominant quadrant, 
suggesting a possibility for the intervention having a positive effect with lower costs compared to 
usual treatment. Thus, the favorable effects of the intervention on HRQoL as we measured it were 
achieved cost-neutrally. 
Our trial had several strengths. It was based on an RCT with sufficient power to explore the effects of 
the intervention on HRQoL. Our intervention was designed to be affordable, feasible, and transferable 
to other contexts in primary care. It was based on comprehensive geriatric assessment (19-20) and on 
validated measurements, and the participants reported being mainly satisfied with the intervention 
(15). 
We included all participants in the cost analysis (true intention-to-treat) and the dropout rate for the 
analysis of QALYs was low for a study targeting older people (31-32), with 88% of the intervention 
group and 85% of the control group having at least two 15D measurements included in the analysis. In 
addition, we performed an imputation for modified intention-to-treat analysis of QALYs and the 
results did not differ notably from the original analysis. We had complete information of service use 
and costs of all participants until the time of death or end of the follow-up, as these data were retrieved 
from registers. We used a patient-relevant outcome measure, HRQoL assessed using the 15D, which is 
well validated and has worked well with older populations in earlier studies (16,33-34). The single 
composite score of 15D is particularly valid for deriving QALYs gained (17). The use of health and 
social services in Finland is reliably recorded in medical records and central registers, yielding solid 
data for the evaluation of the cost effectiveness of the intervention. The intervention and control 
groups had comparable rates for use of services at baseline. The intervention visits and related costs 
were not included in the services use data collected from health-care information systems and 
databases. We assessed the intervention costs individually, while any additional health and social 
services costs incurred in the course of the intervention were included in the standard services use data 
kept by health-care information systems and databases. This eliminated the possibility of double 
counting the intervention visits or costs. 
Our study had some limitations. We could not blind the participants or the professionals delivering the 
intervention due to the nature of the study. The data was not blinded at the time of the analysis, but we 
followed strictly the intention-to-treat principles. The lack of difference between the intervention and 




















differences in mortality between the groups. Performing a qualitative study prior to the RCT might 
have made the intervention more personalized (13,35). However, this protocolized intervention was 
feasible (15) and in its present form also easily transferable in Finnish health care system. 
Furthermore, a pilot study might have reduced uncertainties in the trial design (35-36). As the 
participants were from the area of one municipality in Finland, the sample might be too homogenous 
considering generalization of the findings to other populations. Interventions which are part of 
complex health care services have to be considered in the context of the underlying health care system 
(35,37). 
Results on the cost effectiveness of PHVs have varied in earlier papers, and results of economic 
evaluations are challenging to compare as they have to be interpreted in national contexts. Overall, a 
small number of the studies concerning PHVs report both HRQoL outcomes and costs of health 
services use (2,5,12). Our study did not show a significant difference between the control and 
intervention groups in the mean use or costs of services, which is in line with earlier findings (2,5,38). 
Some studies have found favorable effects of PHVs on functional status or on HRQoL without 
increased costs, a finding that our study confirms (2,37). However, other studies have reported no 
clear effects on either clinical outcomes or total costs (5,12). Metzelthin et al. found in their study only 
2% of ICERs lay in the dominant quadrant (5), compared to our finding of 60% of ICERs in the 
dominant quadrant. Our study might have been able to show favorable effects on HRQoL due to the 
satisfactory number of participants, the multiprofessional nature of the intervention and its reliance on 
comprehensive geriatric assessement, and the use of a primary outcome measure based on a tool that 
has previously been shown to be sensitive to change in older populations (14,39). 
There can be other reasons for the lack of effect on use and costs of services: As the distribution of 
services use and costs is usually distinctly positively skewed, showing a statistically significant 
difference between groups is difficult and requires a large number of participants in the study arms. 
Our sample size was calculated based on the primary outcome, HRQoL in terms of 15D index scores, 
and therefore it is possible that the power of our study was not large enough to show such a difference. 
The difference between the control and intervention groups in the change in the 15D score, although 
small (0.015), is considered clinically significant compared to the change found in earlier research 
(12,39): at the same time there was no significant difference in QALYs gained between the groups. 
This is likely due to several reasons. The difference in change in 15D scores was small, and the effect 
diluted in the second year of follow-up. We did not detect a significant difference in mortality between 
two groups. This explains why the QALYs of the two groups were fairly similar. The cost-
effectiveness plane suggests that the intervention might have favorable effects with lower costs than 
for standard care (5,20). As there was no significant difference in mean total costs per person years, 
we interpret this result as the intervention having favorable effects without an increase in costs. 
It is unclear if continuing the support past the initial year of intervention would have yielded additional 
effects on HRQoL. This should be further studied. Considering that we did not have the power to 
detect differences in mortality in this trial, and the effect on HRQoL diluted in the second year of 
follow-up, further follow-up on use and costs of health-care and social services of the participants in 
this trial would not likely yield more information on the cost effectiveness. When planning future 
studies concerning the cost effectiveness of multiprofessional PHV programs, the power needed to 
show differences in health-care and social services costs between groups should be considered. The 
increased understanding of the complexity of health care and studying complex interventions offer 




















Health care is experiencing several changes and challenges, one of which is the increase of multi-
morbid older people. The understanding of complex health care interventions and their research has 
increased during recent years. New ways of studying these interventions have been introduced in 
addition to conventional research methods (37). However, individually randomized trials are still seen 
important when they are technically and ethically applicable (35). 
4.1 Conclusions 
The multiprofessional PHV intervention showed cost-neutral favorable effects on HRQoL. We did not 
detect differences in total use or costs of services or in QALYs gained, but the ICER analysis 
suggested the intervention to be favorable and cost-effective.  
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Table 1: Baseline Characteristics of the Participants. 
 
 Intervention 
(N = 211) 
Control 
(N = 211) 
p value 
Females, n (%) 138 (65) 136 (65) 0.84 
Age, mean (SD) 80.8 (4.3) 81.3 (4.3) 0.20 














Education, years (SD), mean (SD) 10.0 (3.9) 9.8 (3.7) 0.63 
Charlson comorbidity index, mean (SD) 1.3 (1.3) 1.4 (1.5) 0.61 
HRQoL: 15D score mean (SD) 0.823 (0.110) 0.824 (0.111) 0.87 
Primary care, mean (SD)    
   Nurse visits 2.31 (3.70) 2.57 (4.11) 0.52 
   General practitioner visits 1.93 (1.82) 1.89 (1.89) 0.83 
   Other specialists’ visits 0.61 (1.87) 0.44 (1.09) 0.27 
   Primary care ward, days 1.00 (6.44) 1.18 (5.76) 0.77 
   Day care, days 0.47 (4.92) 1.42 (9.43) 0.21 
Specialized medical care, mean (SD)    
   Outpatient visits 1.13 (1.86) 1.12 (1.95) 0.98 
   Emergency department visits 0.69 (1.25) 0.63 (1.14) 0.63 
 Hospital ward, care days  0.99 (3.18) 1.16 (5.03) 0.70 




















Table 2. Use and Costs of Health and Social Services During the 24-month Follow Up, Per Person Years (pyrs) 


















) Mean difference in costs (95% CI)
b
 
Primary care       
   Nurse visits 2.28 (0.17) 2.37 (0.19)  229 (17) 237 (19) -8 (-61 to 43) 
   General practitioner visits 2.04 (0.11) 1.95 (0.11)  474 (26) 449 (25) 25 (-41 to 99) 
   Other specialists’ visits
c
 0.59 (0.07) 0.67 (0.07)  94 (11) 104 (11) -10 (-40 to 21) 
   Home care, visits 6.73 (1.93) 11.81 (4.26)  596 (175) 1028 (374) -433 (-1459 to 183) 
   Primary care ward, days 3.58 (0.89) 4.34 (0.97)  1572 (384) 1766 (373) -194 (-1224 to 904) 
   Day care, days 0.57 (0.22) 1.05 (0.38)  117 (47) 200 (73) -83 (-286 to 61) 
   Respite care, days 0.19 (0.12) 0.00 (0.00)   68 (40) 0 (0) 68 (-17 to 217) 
Specialised medical care       
   Outpatient visits 0.94 (0.10) 1.26 (0.12)  518 (52) 673 (63) -155 (-324 to 3) 
   Emergency department visits 0.79 (0.08) 0.85 (0.08)  464 (45) 469 (42) -6 (-119 to 117) 
   Hospital ward, care days 1.61 (0.23) 2.10 (0.35)  2488 (356) 2973 (508) -485 (-1871 to 607) 




















Total    6929 (846) 8277 (1089) -1349 (-4119 to 1172) 
Intervention costs    382 ..  
Total including intervention    7310 (849) 8277 (1089) -967 (-3766 to 1633) 
a
 Bootstrap type standard error of mean. 
b  
The 95% confidence intervals were obtained by bias-corrected bootstrapping (10,000 replications). 
c 






























Mean (95% CI) 
Baseline 0.823 (0.110) 0.824 (0.111)  
12 month 0.827 (0.126) 0.819 (0.120) 0.015 (0.002 to 0.028), p=0.020 
24 month 0.825 (0.116) 0.816 (0.120) 0.009 (-0.013 to 0.031), p=0.41 
a
























Figure 1 Participant flow during the trial and participants included in analysis. 
Figure 2 Incremental cost-effectiveness planes for costs and health-related quality-of-life outcomes of 
5000 bootstrapped replicates. The percentages in the four quadrants denote the percent of the estimates 
that fell within each quadrant. 
Table 1 Baseline Characteristics of the Participants. 
Table 2 Use and Costs of Health and Social Services During the 24-month Follow Up, Per Person 
Years (pyrs) 
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